Burning Rock Biotech (BNR) Competitors $9.34 -0.52 (-5.27%) Closing price 08/22/2025 03:48 PM EasternExtended Trading$9.22 -0.12 (-1.23%) As of 08/22/2025 07:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BNR vs. LFMD, VMD, XGN, DCGO, CORBF, NAKA, EUDA, QIPT, SERA, and KDLYShould you be buying Burning Rock Biotech stock or one of its competitors? The main competitors of Burning Rock Biotech include LifeMD (LFMD), Viemed Healthcare (VMD), Exagen (XGN), DocGo (DCGO), Global Cord Blood (CORBF), KindlyMD (NAKA), EUDA Health (EUDA), Quipt Home Medical (QIPT), Sera Prognostics (SERA), and Kindly MD (KDLY). These companies are all part of the "healthcare" industry. Burning Rock Biotech vs. Its Competitors LifeMD Viemed Healthcare Exagen DocGo Global Cord Blood KindlyMD EUDA Health Quipt Home Medical Sera Prognostics Kindly MD LifeMD (NASDAQ:LFMD) and Burning Rock Biotech (NASDAQ:BNR) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, dividends, institutional ownership, risk, profitability, valuation and media sentiment. Do institutionals and insiders have more ownership in LFMD or BNR? 35.5% of LifeMD shares are owned by institutional investors. Comparatively, 30.0% of Burning Rock Biotech shares are owned by institutional investors. 18.4% of LifeMD shares are owned by company insiders. Comparatively, 30.3% of Burning Rock Biotech shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Is LFMD or BNR more profitable? LifeMD has a net margin of -2.41% compared to Burning Rock Biotech's net margin of -45.41%. LifeMD's return on equity of 0.00% beat Burning Rock Biotech's return on equity.Company Net Margins Return on Equity Return on Assets LifeMD-2.41% N/A -8.11% Burning Rock Biotech -45.41%-38.33%-25.34% Which has stronger valuation and earnings, LFMD or BNR? LifeMD has higher revenue and earnings than Burning Rock Biotech. LifeMD is trading at a lower price-to-earnings ratio than Burning Rock Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLifeMD$212.45M1.41-$18.88M-$0.21-30.14Burning Rock Biotech$70.67M1.42-$47.49M-$1.89-4.94 Does the media refer more to LFMD or BNR? In the previous week, LifeMD had 7 more articles in the media than Burning Rock Biotech. MarketBeat recorded 8 mentions for LifeMD and 1 mentions for Burning Rock Biotech. LifeMD's average media sentiment score of 0.09 beat Burning Rock Biotech's score of 0.00 indicating that LifeMD is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment LifeMD 0 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral Burning Rock Biotech 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts recommend LFMD or BNR? LifeMD presently has a consensus price target of $13.17, suggesting a potential upside of 108.00%. Given LifeMD's stronger consensus rating and higher probable upside, research analysts clearly believe LifeMD is more favorable than Burning Rock Biotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LifeMD 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.00Burning Rock Biotech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has more risk and volatility, LFMD or BNR? LifeMD has a beta of 1.72, indicating that its stock price is 72% more volatile than the S&P 500. Comparatively, Burning Rock Biotech has a beta of 0.83, indicating that its stock price is 17% less volatile than the S&P 500. SummaryLifeMD beats Burning Rock Biotech on 14 of the 17 factors compared between the two stocks. Get Burning Rock Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for BNR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BNR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BNR vs. The Competition Export to ExcelMetricBurning Rock BiotechTechnology Services IndustryBusiness SectorNASDAQ ExchangeMarket Cap$100.49M$2.68B$24.72B$9.76BDividend YieldN/A1.55%2.80%4.06%P/E Ratio-4.9423.5028.7026.05Price / Sales1.4237.1330.2688.42Price / CashN/A43.5426.6459.36Price / Book1.266.626.026.60Net Income-$47.49M$34.75M$199.12M$265.65M7 Day Performance24.87%1.82%1.47%2.00%1 Month Performance11.59%-4.67%-1.76%0.46%1 Year Performance55.67%33.20%31.68%18.88% Burning Rock Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BNRBurning Rock Biotech0.2752 of 5 stars$9.34-5.3%N/A+56.4%$100.49M$70.67M-4.941,390Upcoming EarningsGap DownLFMDLifeMD2.6041 of 5 stars$6.51+1.2%$12.86+97.5%+16.1%$304.89M$212.45M-31.00230News CoverageVMDViemed Healthcare2.0463 of 5 stars$6.92+0.4%N/A-1.1%$267.23M$224.26M20.351,179Positive NewsXGNExagen3.6351 of 5 stars$9.75+2.7%$11.25+15.4%+223.7%$208.82M$55.64M-10.96220Short Interest ↑DCGODocGo2.1187 of 5 stars$1.68+3.7%$3.56+111.9%-53.8%$158.45M$616.55M-8.844,407News CoverageAnalyst ForecastCORBFGlobal Cord BloodN/A$1.25+127.3%N/A+53.5%$151.94M$196.12M0.001,200NAKAKindlyMDN/A$12.02-12.1%N/AN/A$103.17M$2.72M-13.98N/ANews CoverageEUDAEUDA HealthN/A$2.64+3.9%N/A-42.9%$94.38M$4.01M0.002Gap UpQIPTQuipt Home Medical3.3291 of 5 stars$2.26+10.8%$2.85+26.1%-24.8%$88.63M$245.91M-9.421,200News CoverageAnalyst ForecastSERASera Prognostics1.197 of 5 stars$2.38+5.8%N/A-68.0%$84.76M$80K-2.80120News CoveragePositive NewsKDLYKindly MDN/A$13.67-9.0%N/A+511.3%$82.32M$2.47M-17.75N/APositive NewsGap Up Related Companies and Tools Related Companies LifeMD Competitors Viemed Healthcare Competitors Exagen Competitors DocGo Competitors Global Cord Blood Competitors KindlyMD Competitors EUDA Health Competitors Quipt Home Medical Competitors Sera Prognostics Competitors Kindly MD Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BNR) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCover all your expenses with just $118,000 invested?Generate up to $5,000/month with 10X less money? That's what every financial advisor tells you. But I just ...Investors Alley | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredTrump’s “new dollar” could shock Americans"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | SponsoredTrump’s SHOCKING Plan to Create MASSIVE Wealth for AmericansJames Altucher says Donald Trump just made a move so surprising, it could go down as the most lucrative presid...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Burning Rock Biotech Limited Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Burning Rock Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access